Educational Webinars

An educational webinar series featuring leading clinical experts in the field of breast radiology and innovative cancer therapy hosted by iCAD and Xoft

Access Recorded Programs

Sept
15th

What is Real AI: Adopting Artificial Intelligence

Tuesday, September 15  at 7 pm ET/4 pm PT

• Grant Davies, CEO, Solis Mammography (panelist)
• Randy Hicks, MD, MBA, Co-owner and CEO of Regional Medical Imaging (panelist)
• Senthil Periaswamy, PhD, Chief Research Scientist, VP of Clinical Innovation, iCAD, Inc. (panelist)
• Greg Sorensen, MD, CEO and Co-founder of DeepHealth, Inc. (panelist)
• Lawrence Tanenbaum, MD, CTO, Director of Advanced Imaging, VP, Radnet Inc. (panelist)
• Susan Wood, PhD, President and CEO, VIDA (moderator)

This free virtual roundtable will feature leading experts in artificial intelligence (AI) and cancer detection, who will share best practices on how to leverage AI in a clinical setting – in the era of COVID-19 and beyond. Join us to learn how AI can improve efficiency and enhance patient care in your practice.

Play Recording>

July
21st

Satisfying the Triple Aim: IORT and its Benefits for Clinicians, Patients and Payers

Tuesday, July 21st, 12:00 pm - 1:00 pm EDT

Olga Ivanov MD, FACS, Medical Director, IV Lounge Wellness and Health

Charles Wesley Hodge, MD, Radiation Oncologist, AdventHealth

Monica Reed, MD, CEO of AdventHealth state of the art facility, Celebration Health

Intraoperative radiation therapy (IORT) offers a unique trifecta of benefits for clinicians, patients, and payers. In partnership with the Society for Radiation Oncology Administrators (SROA), leading breast cancer specialists will share clinical experiences and expert opinions regarding this targeted, single-fraction radiation treatment option, which optimizes workflow and allows women who are candidates to get the treatment they need, while minimizing potential COVID-19 exposure to patients and clinicians. Join this virtual webinar to learn more about IORT and how it is positioned to enhance patient care – in the era of COVID-19 and beyond.

SROA Members- complimentary

Non-Members-$30

Play Recording>

July
7th

Webinaire, L’Intelligence Artificielle pour une meilleure détection du cancer du sein

Présenté par le Dr Toubiana et Benillouche, CSE Paris. Comment les solutions ProFound AI™ pour la mammographie et la tomosynthèse assistent le radiologue au quotidien. La solution ProFound AI™ est utilisée au centre d’imagerie CSE à Paris depuis Septembre 2018. Les Drs Toubiana et Benillouche montrent, au travers de nombreux cas cliniques,  comment l’utilisation de ce nouvel outil a changé leur routine clinique pour l’analyse des mammographies 2D et tomosynthèses.

Lire l'enregistrement>

June
30th

IORT Applied During and Post Pandemic Times

Tuesday, June 30, 2020 10:00 AM - 11:00 AM EDT

Join us for an informative webinar featuring leading breast cancer experts from Anadolu Medical Center in Istanbul, Turkey who will discuss how breast intraoperative radiation therapy (IORT) is optimizing workflow and minimizing COVID-19 exposure to patients and clinicians, while preserving high-quality care. Prof. Hale Çağlar, Metin Çakmakçı, and Nadir Küçük, MSc. will share their views on the impact of the pandemic on their practice, hypofractionation, IORT as boost and emerging IORT applications.

Play Recording>

June
25th

Electronic Brachytherapy (eBx) for Gynecological Tumors

Thu, Jun 25, 2020 8:00 AM - 9:00 AM EDT

Gynecological cancers require, in many cases, the use of brachytherapy as part of the standard course of treatment. The Xoft System is FDA-cleared, CE marked and licensed in a growing number of countries for the treatment of cancer anywhere in the body. It uses a miniaturized x-ray source to deliver a precise, concentrated dose of radiation directly to the tumor site, while minimizing risk of damage to healthy tissue in nearby areas of the body. The Xoft System allows clinicians to perform gynecological brachytherapy with multiple dwell positions to deliver the prescribed dose without the inconvenience of radioactive sources. Learn more about gynecological cancer treatment with the Xoft System from Dr. Arantxa Campos and Dr. Sonia Flamarique from Miguel Servet University Hospital from Zaragoza, Spain.

Play Recording>

June
23rd

In Partnership with the TME Breast Care Network “It’s TiME” Series: Behind the Mask – Operating with Precision, Efficiency, and Empathy

Peter D. Beitsch, MD FACS, Director, Dallas Breast Center, Managing Partner, TME Breast Care Network, Past President, ASBS

Rakesh Patel, MD, Managing Partner, Precision Cancer Specialists, Inc., Managing Partner, TME Breast Care Network, Past President, ABS

Barry Rosen, MD FACS, Breast Surgeon, Advocate Healthcare, Managing Partner, TME Breast Care Network

Walton Taylor, MD FACS, Breast Surgeon, Texas Health Physicians Group, Managing Partner, TME Breast Care Network, Past President, ASBS

Pat Whitworth, MD, Director, Nashville Breast Center, Managing Partner, TME Breast Care Network, Past Chairman, ASBS

Tuesday, June 23, 2020 7:00 pm ET

While Coronavirus force functioned healthcare systems into care delivery redesign, physicians were challenged to rethink best-in-class surgical and radiation practice. Reoperation, re-excision, and unnecessary treatment time now threaten more than margin efficiency and patient outcomes – inefficiency is an opportunity for unintended exposure. Panelists will discuss the additional complexities of providing care today, from "screen-side" manner to process improvement and adoption of new technologies and invite you to join the discussion.

Play Recording>

June
9th

In Partnership with the TME Breast Care Network “It’s TiME” Series: Catching up with Catching Cancer Early

Peter D. Beitsch, MD FACS, Director, Dallas Breast Center, Managing Partner, TME Breast Care Network, Past President, ASBS

Rakesh Patel, MD, Managing Partner, Precision Cancer Specialists, Inc., Managing Partner, TME Breast Care Network, Past President, ABS

Barry Rosen, MD FACS, Breast Surgeon, Advocate Healthcare, Managing Partner, TME Breast Care Network

Walton Taylor, MD FACS, Breast Surgeon, Texas Health Physicians Group, Managing Partner, TME Breast Care Network, Past President, ASBS

Pat Whitworth, MD, Director, Nashville Breast Center, Managing Partner, TME Breast Care Network, Past Chairman, ASBS

Tuesday, June 9, 2020 7:00 pm ET

Adopting the right technology and innovation can yield improved patient access and outcomes as the industry navigates the back log of elective procedures from screening to surgery. Specifically in this session, TME leaders will explore the importance of maintaining a focus on population health and how to support patients through at-home preventative care.  Panelists will deep dive into AI, genetic testing, and telehealth and invite you to join the discussion.

Play Recording>

June
4th

The Impact of COVID-19 on Breast Cancer Surgery and Targeted Radiation Therapy

Charles Wesley Hodge, MD, Radiation Oncologist, Florida Hospital Celebration Health/AdventHealth

Michael Howard, PhD DABMP RSO, Director of Oncology Services, Chief of Medical Physics, Sarah Cannon Cancer Institute, Parkridge Medical Center, HCA Healthcare

Sadia Khan, DO, FACS, Assistant Clinical Professor of Surgery at Keck School of Medicine, USC, Director of Integrative Breast Oncology at Hoag Breast Program

Barry Rosen, MD FACS, Breast Surgeon, Advocate Healthcare, Managing Partner, TME Breast Care Network

Rakesh Patel, MD (Moderator), Managing Partner, Precision Cancer Specialists, Inc., Managing Partner, TME Breast Care NetworkPast President, ABS

Thursday, June 4, 2020 7:00 PM - 8:00 PM EDT

How are clinicians changing their approach to cancer treatment during the COVID-19 pandemic? Join us for a free virtual roundtable featuring leading breast cancer experts who will share best practices and discuss how targeted radiation therapy is emerging as a way to optimize workflow and minimize COVID-19 exposure to patients and clinicians, while preserving high-quality care.

Play Recording>

May
28th

GE Healthcare: Making AI Meaningful - How AI is Being Used to Transform Radiology Practices featuring Randy D. Hicks, M.D., M.B.A.

Ajay Choudhri, M.D.
Dr. Choudhri is the Chairman and Medical Director of the Department of Radiology at Capital Health.

Amit Gupta, M.D. is a Cardiothoracic Radiologist and Modality director of Diagnostic Radiography at University Hospitals Cleveland Medical Center and Assistant Professor of Radiology at Case Western Reserve University, Cleveland.

Randy D. Hicks, M.D., M.B.A.
Dr. Hicks is the co-owner and CEO of RMI. He is a distinguished practitioner, thought leader, and published researcher in women’s imaging for breast cancer.

Amy K. Patel M.D.
Dr. Patel is a Breast Radiologist, Medical Director of The Women's Imaging Center at Liberty Hospital, and Assistant Professor of Radiology at the University of Missouri-Kansas City School of Medicine.

Thursday, May 28, 2020 at 12:00 pm EDT

The use of Artificial Intelligence (AI) in radiological applications is no longer an idea - it is becoming a necessity to help deliver the highest possible patient care. Just as PACS and RIS systems were the crucial infrastructure implementation of the last 20 years in the transition of radiology from film to digital, AI is one of the new crucial enabling technologies of this decade’s radiology practices.

Join our roundtable discussion with innovative leaders across multiple disciplines to learn how they are deploying and benefiting from the use of AI in their practices. Hear firsthand how AI-based clinical applications are helpful not just in assisting their radiologists to detect stroke, cancers and other abnormalities, but are also being deployed to help reduce time to read and prioritize caseloads.

Play Recording>

May
21st

Xoft Breast Intraoperative Radiation Therapy (IORT) for Early Stage Breast Cancer Treatment

Dr. Janie Grumley, MD FACS
Director of the Margie Petersen Breast Center
Director of the Comprehensive Breast Program, John Wayne Cancer Institute
Providence Saint John’s Health Center
Associate Professor of Surgery, John Wayne Cancer Institute

Thursday, May 21, 2020 4:00 pm EDT

Explore an innovative approach to breast cancer treatment. The Xoft System uses a miniaturized x-ray source to deliver a precise, concentrated dose of radiation directly to the tumor site, while minimizing risk of damage to healthy tissue in nearby areas of the body. For the treatment of early-stage breast cancer, intraoperative radiation therapy (IORT) with the Xoft System allows appropriately selected patients to potentially replace four to six weeks of post-operative external beam radiation therapy (EBRT) with a single-fraction of radiation that can last as little as eight minutes. Join us for a free webinar to learn how IORT has optimized Dr. Grumley’s workflow and how targeted radiation therapy is emerging as a way to minimize COVID-19 exposure to patients and clinicians, while preserving high quality care.

Play Recording>

May
19th

Xoft Intraoperative Radiation Therapy (IORT) for Brain Cancer: Local Tumor Control in Patients with Recurrent Glioblastoma

Alexey Krivoshapkin, Head of Neurosurgery branch of Neurology and Neurosurgery School, MD, Professor, Neurosurgeon at the European Medical Center in Moscow, Russia

Alexey Gaytan, MD, PhD, Neurosurgeon at the European Medical Center in Moscow, Russia

Tuesday, May 19, 2020 | 12:00 PM - 1:00 PM EDT | 18:00 - 19:00 CET

Worldwide, almost 297,000 cases of brain and nervous system tumors are diagnosed per year.1 Glioblastoma is the most common and aggressive type of malignant primary brain tumor, with a median survival of 10-12 months.2,3 Treatment for GBM typically involves surgical removal, followed by radiation therapy or chemotherapy. There has been recent interest in intraoperative radiotherapy (IORT) as a potential treatment option for effective local tumor control. This approach is conceptually appealing because IORT allows for the delivery of a large, localized radiation dose to the tumor bed and the micro- and macroscopic tumor remnants in the vicinity of the surgical cavity. The Xoft System is FDA-cleared, CE marked and licensed in a growing number of countries for the treatment of cancer anywhere in the body. It uses a miniaturized x-ray source to deliver a precise, concentrated dose of radiation directly to the tumor site, while minimizing risk of damage to healthy tissue in nearby areas of the body. Learn more about the promising preliminary results of this procedure after GBM relapse. Join Professor Krivoshapkin & Dr. Gaytan for an informative product showcase discussing Neuro IORT and the benefits it offers to physicians, facilities and patients.

Play Recording >

 

 

References:

  1. WHO, IARC, Globocan Cancer Incidence and Mortality Worldwide in 2018. Accessed via https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf.
  2. Tamimi AF, Juweid M. Epidemiology and Outcome of Glioblastoma. In: De Vleeschouwer S, editor. Glioblastoma [Internet]. Brisbane (AU): Codon Publications; 2017 Sep 27. Chapter 8. Accessed via https://www.ncbi.nlm.nih.gov/books/NBK470003.
  3. Pan E, Prados MD. Glioblastoma Multiforme and Anaplastic Astrocytoma. In: Kufe DW, Pollock RE, Weichselbaum RR, et al., editors. Holland-Frei Cancer Medicine. 6th edition. Hamilton (ON): BC Decker; 2003. Accessed via https://www.ncbi.nlm.nih.gov/books/NBK12526/.

May

18th

How Radiologists can Easily and Effortlessly Integrate Artificial Intelligence in Breast Screening During and After the COVID-19 Crisis

Michael Gruber, MD, Radiologist, Co-owner of a private radiology institute in Baden, Austria

Monday, May 18, 2020 11:00 AM - 12:00 PM EDT | 17:00 - 18:00 CET

Michael Gruber, MD, will explain how he uses ProFound AI in his breast screening program, how AI was easy to implement and immediately assisted him in addressing the challenges of tomosynthesis by improving reading time and cancer detection rates, while reducing false positives and unnecessary patient recalls. Dr. Gruber will also share his vision on how ProFound AI can help radiologists with post-COVID-19 challenges. Michael Gruber, MD, radiologist, is co-owner of a private radiology institute in Baden, Austria. This center is one of many sites of the Austrian breast screening program. He is a member of numerous radiological societies. He is also Executive Vice President of the Association for Medical Radiation Protection in Austria (VMSÖ) and a co-opted board member of the Austrian X-ray Society.

Play Recording>

May
14th

Xoft Intraoperative Radiation Therapy (IORT) for Brain Cancer: Local Tumor Control in Patients with Recurrent Glioblastoma

Alexey Krivoshapkin, Head of Neurosurgery branch of Neurology and Neurosurgery School, MD, Professor, Neurosurgeon at the European Medical Center in Moscow, Russia

Alexey Gaytan, MD, PhD, Neurosurgeon at the European Medical Center in Moscow, Russia

Thursday, May 14, 2020 | 8:00 AM - 9:00 AM EDT and 14:00 – 15:00 CET

Worldwide, almost 297,000 cases of brain and nervous system tumors are diagnosed per year.1 Glioblastoma is the most common and aggressive type of malignant primary brain tumor, with a median survival of 10-12 months.2,3 Treatment for GBM typically involves surgical removal, followed by radiation therapy or chemotherapy. There has been recent interest in intraoperative radiotherapy (IORT) as a potential treatment option for effective local tumor control. This approach is conceptually appealing because IORT allows for the delivery of a large, localized radiation dose to the tumor bed and the micro- and macroscopic tumor remnants in the vicinity of the surgical cavity. The Xoft System is FDA-cleared, CE marked and licensed in a growing number of countries for the treatment of cancer anywhere in the body. It uses a miniaturized x-ray source to deliver a precise, concentrated dose of radiation directly to the tumor site, while minimizing risk of damage to healthy tissue in nearby areas of the body. Learn more about the promising preliminary results of this procedure after GBM relapse. Join Professor Krivoshapkin & Dr. Gaytan for an informative product showcase discussing Neuro IORT and the benefits it offers to physicians, facilities and patients.

Play Recording >

 

 

References:

  1. WHO, IARC, Globocan Cancer Incidence and Mortality Worldwide in 2018. Accessed via https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf.
  2. Tamimi AF, Juweid M. Epidemiology and Outcome of Glioblastoma. In: De Vleeschouwer S, editor. Glioblastoma [Internet]. Brisbane (AU): Codon Publications; 2017 Sep 27. Chapter 8. Accessed via https://www.ncbi.nlm.nih.gov/books/NBK470003.
  3. Pan E, Prados MD. Glioblastoma Multiforme and Anaplastic Astrocytoma. In: Kufe DW, Pollock RE, Weichselbaum RR, et al., editors. Holland-Frei Cancer Medicine. 6th edition. Hamilton (ON): BC Decker; 2003. Accessed via https://www.ncbi.nlm.nih.gov/books/NBK12526/.

May

7th

Live Roundtable Replay and Q&A with Dr. Randy Hicks: Breast Cancer Screening and Treatment in the Era of COVID-19

Randy Hicks, MD, MBA, Co-owner and CEO of Regional Medical Imaging

Thu, May 7, 2020 4:00 PM - 5:30 PM EDT

In partnership with the Targeted Medical Education (TME) Breast Care Network, our Virtual Roundtable Event featured leading breast cancer specialists nationwide who discussed their perspectives and experience regarding how COVID-19 is changing the future of breast cancer care. Join us for a replay of this important conversation with a live question and answer session to follow featuring Randy Hicks, MD, MBA, Co-owner and CEO of Regional Medical Imaging. In an interactive discussion, Dr. Hicks will address your questions on how artificial intelligence can optimize operational efficiency, clinician confidence and patient outcomes during the COVID-19 pandemic and beyond.

Play Roundtable Recording>

Play Q&A Recording>

May

4th

Assisting Radiologists: How can AI Improve the Efficiency of Breast Healthcare After COVID-19 ?

Dr. Axel Gräwingholt, Head of the Department of Mammography Screening, Radiologie am Theater, Germany

Mon, May 4, 2020 12:00 PM - 1:00 PM EDT | 18:00 - 19:00 CET

How can AI improve the efficiency of breast healthcare after COVID-19 and help radiologists with their increased workload?  After the COVID-19 crisis, radiologists will have to deal with an influx of patients due to rescheduled examinations. These exams will include both screening and diagnostics and will have to be handled in a very efficient manner. Artificial intelligence can be a strong ally for all radiologists and help them overcome these challenges.

* Webinar intended for an EU audience.

Play Recording>

April
30th

Work Smarter, Not Harder: Boost your Bottom Line with AI

Dr. Gabriele Pedicelli, Radiologist at Wooster Community Hospital

Thursday, April 30 at 3:00 pm EDT

Are you working harder or working smarter? Artificial intelligence (AI) can not only improve your workflow, it can also have a positive impact on your practice’s bottom line. Join us for a brief discussion with Dr. Gabriele Pedicelli, radiologist at Wooster Community Hospital, to learn how a leading-edge AI tool can empower your practice to increase the number of cases seen per day and increase revenues without increasing expenses.

Play Recording>

April
23rd

Trustworthy Tools: Leveraging the Power of AI to Improve Accuracy

Lisa M. Sheppard, MD, PINK Breast

Thursday, April 23 at 4:00 pm EDT

False positives and patient callbacks can cause unnecessary stress for patients, but a cutting-edge artificial intelligence (AI) solution offers a tool radiologists can trust to improve reading accuracy. Join us for a brief discussion with Lisa Sheppard, MD, radiologist at PINK Breast Center, to learn how AI helped improve her practice’s biopsy accuracy, while also reducing the number of false positives and callbacks.

Play Recording>

April
21st

Assisting Radiologists: How can AI Improve the Efficiency of Breast Healthcare After COVID-19 ?

Dr. Axel Gräwingholt, Head of the Department of Mammography Screening, Radiologie am Theater, Germany

Tue, Apr 21, 2020 12:00 PM - 1:00 PM EDT | 18:00 - 19:00 CET

How can AI improve the efficiency of breast healthcare after COVID-19 and help radiologists with their increased workload?  After the COVID-19 crisis, radiologists will have to deal with an influx of patients due to rescheduled examinations. These exams will include both screening and diagnostics and will have to be handled in a very efficient manner. Artificial intelligence can be a strong ally for all radiologists and help them overcome these challenges.

* Webinar intended for an EU audience.

Play Recording>

April
21st

Breast Care Virtual Roundtable: How is breast cancer screening and treatment evolving in the era of COVID-19?

Tuesday, April 21 at 7 pm EDT | 4 pm PDT

In partnership with the Targeted Medical Education (TME) Breast Care Network, our Virtual Roundtable Event featured leading breast cancer specialists nationwide who discussed their perspectives and experience regarding how COVID-19 is changing the future of breast cancer care. Attendees shared their insights in an open forum discussion and learned how to enhance patient care during the COVID-19 pandemic and beyond.

Play Recording>

April
16th

The Power of Artificial Intelligence for Digital Breast Tomosynthesis

Dr. Mark Traill, University of Michigan, Metro Health

Thursday, April 16 at 1:00 pm EDT

Join us for an informative discussion about how the concurrent use of AI improves sensitivity, specificity and reading time when reading Digital Breast Tomosynthesis (DBT) cases. Dr. Mark Traill will discuss real-world experiences and clinical perspectives in breast health solutions powered by artificial intelligence. Built on the latest deep learning and artificial intelligence (AI) technology, ProFound AI is clinically proven to assist radiologists in addressing the challenges of reading tomosynthesis cases by improving cancer detection rates, reducing false positives and unnecessary patient recalls all while decreasing reading times.

Play Recording>

Stay Connected

Follow us on social media to stay connected and informed on all the latest iCAD news, virtual events and product announcements.

CONNECT WITH iCAD

© 2020, iCAD Inc.  All rights reserved.  iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.